0001179110-21-009865.txt : 20211103 0001179110-21-009865.hdr.sgml : 20211103 20211103185519 ACCESSION NUMBER: 0001179110-21-009865 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211101 FILED AS OF DATE: 20211103 DATE AS OF CHANGE: 20211103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schlanger David J CENTRAL INDEX KEY: 0001576145 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39100 FILM NUMBER: 211377123 MAIL ADDRESS: STREET 1: C/O PROGYNY, INC. STREET 2: 1359 BROADWAY, 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Progyny, Inc. CENTRAL INDEX KEY: 0001551306 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 272220139 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1359 BROADWAY STREET 2: 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: 212-888-3124 MAIL ADDRESS: STREET 1: 1359 BROADWAY STREET 2: 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 FORMER COMPANY: FORMER CONFORMED NAME: Auxogyn, Inc. DATE OF NAME CHANGE: 20150318 FORMER COMPANY: FORMER CONFORMED NAME: Auxogyn Inc DATE OF NAME CHANGE: 20120601 4 1 edgar.xml FORM 4 - X0306 4 2021-11-01 0 0001551306 Progyny, Inc. PGNY 0001576145 Schlanger David J C/O PROGYNY, INC. 1359 BROADWAY, 2ND FL NEW YORK NY 10018 1 1 0 0 Chief Executive Officer Common Stock 2021-11-01 4 M 0 50000 0.91 A 50000 D Common Stock 2021-11-01 4 S 0 22554 61.8279 D 27446 D Common Stock 2021-11-01 4 S 0 24312 62.5223 D 3134 D Common Stock 2021-11-01 4 S 0 3134 63.0451 D 0 D Common Stock 2021-11-02 4 M 0 50000 0.91 A 50000 D Common Stock 2021-11-02 4 S 0 38659 61.7866 D 11341 D Common Stock 2021-11-02 4 S 0 11041 62.2369 D 300 D Common Stock 2021-11-02 4 S 0 300 63.0417 D 0 D Employee Stock Option (right to buy) 0.91 2021-11-01 4 M 0 50000 0 D 2027-08-03 Common Stock 50000 2484384 D Employee Stock Option (right to buy) 0.91 2021-11-02 4 M 0 50000 0 D 2027-08-03 Common Stock 50000 2434384 D Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.49 to $61.995 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7) and (8).The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7) and (8). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.00 to $62.995 inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.00 to $63.17 inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.54 to $61.99, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.00 to $62.99, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.015 to $63.09, inclusive. One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. /s/ Jennifer Bealer, Attorney-in-Fact 2021-11-03